Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Daiichi Sankyo Co. Ltd.
  3. News

Daiichi Sankyo Co. Ltd.

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • News

In News

Daiichi Sankyo is leveraging Azure OpenAI Service to develop generative AI and foster an AI-friendly culture - Microsoft

Microsoft - May 02, 2025

Company Profile: Daiichi Sankyo - pharmaphorum

pharmaphorum - Feb 03, 2025

US approves AstraZeneca, Daiichi's treatment for lung cancer - Reuters

Reuters - Jun 24, 2025

Okuzawa to succeed Sunao Manabe as Daiichi Sankyo CEO - Pharmaceutical Technology

Pharmaceutical Technology - Jan 31, 2025

Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer - Business Wire

Business Wire - Jan 30, 2025

Daiichi Sankyo exec on purposeful data collection - Clinical Trials Arena

Clinical Trials Arena - Nov 21, 2024

Daiichi Sankyo stock jumps on strong earnings and buyback plan - Investing.com

Investing.com - Apr 25, 2025

Qol Holdings Acquires Majority Stake in DAIICHI SANKYO ESPHA - TipRanks

TipRanks - Apr 01, 2025

Daiichi Sankyo to Boost ADC Cancer Drug Production, COO Says - Bloomberg.com

Bloomberg.com - Oct 10, 2024

FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For EGFR-Mutated Lung Cancer - Benzinga

Benzinga - Jun 24, 2025

Japan approves Daiichi Sankyo’s Trop-2 ADC for breast cancer - BioWorld MedTech

BioWorld MedTech - Dec 31, 2024

BioMed X Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment - Contract Pharma

Contract Pharma - Jan 14, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All